This market analysis includes a detailed segmentation of the global human vaccine market by type of human vaccine (preventable human vaccines and therapeutic human vaccines), by composition (mono vaccine and combination vaccines), by route of administration (oral, intramuscular, intranasal, and intradermal), and by geography (Americas, APAC, and Europe). The key vendors analyzed in this report are GlaxoSmithKline, Merck, Pfizer, and Sanofi.
Technavio’s market research analysts estimate the global human vaccine market, to grow at a CAGR of more than 11% between 2016 and 2020. One of the major factors influencing this market’s growth is the inclusion of several pediatric vaccines in the national immunization schedule of various countries, which helps in increasing the consumption of vaccines. The Amkericas is the largest market for human vaccines, owing to the high incidences of infectious diseases and cancers in regions like the US, Canada, and Latin America
The new market research report from Technavio provides a breakdown and analysis of the human vaccine segments by technology.
“The market is witnessing growing public awareness and support from both government and non-government agencies. Recently, it has been observed that organizations like the WHO and the Association of American Physicians (AAP) are regularly organizing programs and camps to spread awareness about the benefits of vaccination. This increase in awareness will help to augment the vaccination coverage across the world, which in turn will result in market growth,” says Imran Mushtaq, Industry Manager, Healthcare & Lifesciences, Technavio Research
The preventable human vaccine segment currently accounts for more than 94% of the total market share and is predicted to grow at an impressive CAGR of more than 10% during the forecast period. Factors such as the inclusion of pediatric vaccinations in the national immunization programs (NIPs) of various countries, public-private initiatives, and the growing focus on the emerging countries will propel market growth in this segment during the estimated period.
The major players in the global human vaccine market include GlaxoSmithKline, Merck, Pfizer, and Sanofi. This market is highly competitive owing to the presence of numerous small and large players that operate on a local or global scale. The vendors in this market compete on the basis of price, quality, and innovation to gain maximum market prominence during the forecast period. The intense level of competition in this market has led an increased number of M&A, wherein smaller entities are being acquired by, or are being merged with, major players.
A more detailed analysis is available in the Technavio report, Global Human Vaccine Market 2016-2020.
We can customize reports by other regions and specific segments upon request.
Other related reports:
- Global Preventable Vaccines Market 2015-2019
- Global Cancer Vaccines Market 2015-2019
- Global Travel Vaccines Market 2015-2019
- Global Therapeutic Vaccines Market 2014-2018
Further reading:
